Vyleesi 00713-0897-04
Generic: Bremelanotide
- Manufacturer
- Cosette Pharmaceuticals, Inc.
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 12, 2025
- Listing Expires
- December 31, 2026
- Application
- NDA210557
Need to source Vyleesi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bremelanotide Acetate | 1.75 mg/.3mL |
Drug Class
Melanocortin Receptor Agonist [EPC]Melanocortin Receptor Agonists [MoA]
Selected Package
00713-0897-04Selected4 SYRINGE in 1 CARTON (0713-0897-04) / .3 mL in 1 SYRINGE (0713-0897-06)